Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate vs propofol for painless colonoscopy sedation
ChiCTR2100048729Phase 4Not yet recruiting
- Sponsor
- Hangzhou Red Cross Hospital
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam in None (2 arms), sponsored by Hangzhou Red Cross Hospital. Primary endpoint: Incidence of hypoxemia. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2100048729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048729.